Rheumatoid Arthritis Trial, Recruiting NCT01425892 Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT01425892
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to read and sign a consent form agreeing to take part in the study
  • People who have been diagnosed with Sjögren's disease (a condition that affects moisture-producing glands) based on established medical classification guidelines
  • People who meet most of the standard criteria for Sjögren's disease but have another health condition that prevents a full official diagnosis under those guidelines
  • People who show some signs of Sjögren's disease — for example, at least two of the standard criteria plus other symptoms commonly linked to the condition (such as fatigue, joint pain, or blood vessel problems), even if those symptoms are not part of the official checklist
  • People who have two or more symptoms commonly associated with Sjögren's disease that are not explained by any other condition, even if they do not meet the standard diagnostic checklist

Who may not be able to join:

  • People who are under 16 years of age
  • People who are unable or unwilling to attend follow-up visits or meet the study's ongoing requirements
  • People whose health condition, mental health history, or current treatment leads the lead researcher to conclude they are not suitable for the study — for example, if another condition better explains their symptoms (confirm with trial site)
  • Employees of the NIH (National Institutes of Health) who report directly to, work alongside, or are a family member of the principal investigator running the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zohreh Khavandgar, D.D.S., National Institute of Dental and Craniofacial Research (NIDCR)

Phone: (301) 594-3097

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Registry
ClinicalTrials.gov
Start date
18 January 2012

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical phenotyping of SjD patients and controls over time Collection of samples for concurrent and future laboratory studies related to the pathogenesis Identification of biomarker candidates in SjD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov